Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
Department of Computer Science of Faculty of Science invites applications for a POSTDOCTORAL RESEARCHER IN ALGORITHMS AND COMPUTATIONAL BIOLOGY starting from September 2025, or as agreed
-
Department of Computer Science of Faculty of Science invites applications for a DOCTORAL RESEARCHER IN ALGORITHMS AND COMPUTATIONAL BIOLOGY starting from September 2025, or as agreed. The Doctoral
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
using unique novel mouse models, spatial technologies and analytical methods. Postdoctoral Researcher in Functional Cancer Microbiome through the NORPOD program NORPOD is a collaborative postdoctoral
-
-Cell Genomics through the NORPOD program NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research
-
. In parallel with your experimental work, you would develop theoretical models in collaboration with our international collaborators. You would also develop advanced image analysis schemes to analyse
-
2019 https://doi.org/10.1038/s41596-018-0110-x and Lara et al., arXiv:2503.21396 https://doi.org/10.48550/arXiv.2503.21396 )). In parallel with your experimental work, you would develop theoretical
-
to the development of reproducible analysis workflows and pipelines. You have a PhD in bioinformatics, computational biology, data science, computer science, genetics or other relevant field. You have successfully
-
intersection of computational biology, biotechnology, and precision medicine. You will contribute to the development of innovative bioinformatics tools and perform in-depth analysis of cutting-edge datasets
-
together University of Helsinki research across nine different units, to address challenges relating to the production, processing, distribution and use of food and drug products without compromising human